Modern genetic approaches to searching for targets for medicinal preparations

Russian Journal of Genetics

Volumn 45, Issue 7, 2009, Pages 761-770

  Sarantseva, S V ^a   Schwarzman, A L ^a,b  

^a PETERSBURG NUCLEAR PHYSICS INSTITUTE   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349957965     PISSN: 10227954     EISSN: 16083369     Source Type: Journal    
DOI: 10.1134/S1022795409070011     Document Type: Review

References (74)

1. Venter, J.C., Adams, M.D., Myers, E.W., et al., The Sequence of the Human Genome, Science, 2001, vol. 291, pp. 1304-1351.
2. National Center for Biotechnology Information: Publicly Funded Programs in Sequencing the Mouse Genome, 2001, www.ncbi.nlm.nih.gov/Traces/traces.cgi.
3. Scriver, C.R., After the Genome-the Phenome, J. Inherited Metabolic Disease, 2004, vol. 27, pp. 305-317.
4. Womack, J.E., Advances in Livestock Genomics: Opening the Barn Door, Genome Res., 2005, vol. 15, pp. 1699-16705.
5. Frantz, S. FDA Publishes Analysis of the Pipeline Problem, Nat. Rev. Drug Discov., 2004, vol. 3, p. 379.
6. Sams-Dodd, F., Target-Based Drug Discovery: Is Something Wrong?, Drug Discov. Today, 2005, vol. 10, pp. 139-147.
7. Butcher, S.P., Target Discovery and Validation in the Post-Genomic Era, Neurochem. Res., 2003, vol. 28, pp. 367-371.
8. Lindsay, M.A., Target Discovery, Nat. Rev. Drug Discov., 2003, vol. 2, pp. 831-838.
9. Hardy, L.W. and Peet, N.P., The Multiple Orthogonal Tools Approach to Define Molecular Causation in the Validation of Drug Gable Targets, Drug Discov. Today, 2004, vol. 9, pp. 117-126.
10. Bentley, A., MacLennan, B., Calvo, J., and Dearolf, C.R., Targeted Recovery of Mutations in Drosophila, Genetics, 2000, vol. 156, pp. 1169-1173.
11. McCallum, C.M., Comai, L., Greene, E.A., and Henikoff, S., Targeted Screening for Induced Mutations, Nat. Biotechnol., 2000, vol. 18, pp. 455-457.
12. Laboratory Methods for the Detection of Mutations and Polymorphisms in DNA 352, Taylor, G.M., Ed., Boca Raton: CRC Press, 1997.
13. Kazazian, H.H., Mobile Elements: Drivers of Genome Evolution, Science, 2004, vol. 303, pp. 1626-1632.
14. Rorth, P., A Modular Misexpression Screen in Drosophila Detecting Tissue-Specific Phenotypes, Proc. Natl. Acad. Sci. USA, 1996, vol. 93, pp. 12418-12422.
15. Adams, M.D. and Sekelsky, J.J., From Sequence to Phenotype: Reverse Genetics in Drosophila melanogaster, Nat. Rev. Genet., 2002, vol. 3, pp. 189-198.
16. Smith, D., Wohlgemuth, J., Calvi, B.R., et al., Hobo Enhancer Trapping Mutagenesis in Drosophila Reveals an Insertion Specificity Different from P Elements, Genetics, 1993, vol. 135, pp. 1063-1076.
17. Horn, C. and Wimmer, E., A Versatile Vector Set for Animal Transgenesis, Dev. Genes Evol., 2000, vol. 210, pp. 630-637.
18. Klinakis, A.G., Zagoraiou, L., Vassilatis, D.K., and Savakis, C., Genome-Wide Insertional Mutagenesis in Human Cells by the Drosophila Mobile Element Minos, EMBO Rep., 2000, vol. 1, pp. 416-421.
19. Keng, V.W., Yae, K., Hayakawa, T., et al., Region-Specific Saturation Germline Mutagenesis in Mice Using the Sleeping Beauty Transposon System, Nat. Methods, 2005, vol. 2, pp. 763-769.
20. Takeda, J., Izsvak Z., Ivics Z. Inerstional Mutagenesis of the Mouse Germline with Sleeping Beauty Transposition, Methods Mol. Biol., 2008, vol. 435, pp. 109-125.
21. Dupuy, A.J. and Neal, G.C., Sleeping Beauty: A Novel Cancer Gene Discovery Tool, Hum. Mol. Genet., 2006, vol. 15, pp. 175-179.
22. Collier, L.S., Carlson, C.M., Ravimohan, S., et al., Cancer Gene Discovery in Solid Tumours Using Transposon-Based Somatic Mutagenesis in the Mouse, Nature, 2005, vol. 436, pp. 272-276.
23. Ivics, Z., Hackett, P.B., Plasterk, R.H., and Izsvak, Z., Molecular Reconstruction of Sleeping Beauty, a Tc1-Like Transposon from Fish, and Its Transposition in Human Cells, Cell, 1997, vol. 91, pp. 501-510.
24. Dupuy, A.J., Fritz, S., and Largaespada, D.A., Transposition and Gene Disruption in the Male Germline of the Mouse, Genesis, 2001, vol. 30, pp. 82-88.
25. Fischer, S.E., Wienholds, E., and Plasterk, R.H., Regulated Transposition of a Fish Transposon in the Mouse Germ Line, Proc. Natl. Acad. Sci. USA, 2001, vol. 98, pp. 6759-6764.
26. Horie, K., Kuroiwa, A., Ikawa, M., et al., Efficient Chromosomal Transposition of a Tc1/Mariner-Like Transposon Sleeping Beauty in Mice, Proc. Natl. Acad. Sci. USA, 2001, vol. 98, pp. 9191-9196.
27. Dupuy, A.J., Akagi, K., Largaespada, D.A., et al., Mammalian Mutagenesis Using a Highly Mobile Somatic Sleeping Beauty Transposon System, Nature, 2005, vol. 436, pp. 221-226.
28. Callahan, R., MMTV-Induced Mutations in Mouse Mammary Tumors: Their Potential Relevance to Human Breast Cancer, Breast Cancer Res. Treat., 1996, vol. 39, pp. 33-44.
29. Mikkers, H. and Berns, A., Retroviral Insertional Mutagenesis: Tagging Cancer Pathways, Adv. Cancer Res., 2003, vol. 88, pp. 53-99.
30. Lazner, F., Gowen, M., Pavasovic, D., and Kola, I., Osteopetrosis and Osteoporosis: Two Sides of the Same Coin, Hum. Mol. Genet., 1999, vol. 8, pp. 1839-1846.
31. Yamashita, D.S. and Dodds, R.A., Cathepsin Kl: Cathepsin K and the Design of Inhibitors of Cathepsin K, Curr. Pharm. Des., 2000, vol. 6, pp. 1-24.
32. Saftig, P., Hunziker, E., Wehmeyer, O., et al., Impaired Osteoclastic Bone Resorption Leads to Osteopetrosis in Cathepsin-K-Deficient Mice, Proc. Natl. Acad. Sci. USA, 1998, vol. 95, pp. 13453-13458.
33. Huszar, D., Lynch, C.A., Fairchild-Huntress, V., et al., Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice, Cell, 1997, vol. 88, pp. 131-141.
34. Chen, A.S., Marsh, D.J., Trumbauer, M.E., et al., Inactivation of the Mouse Melanocortin-3 Receptor Results in Increased Fat Mass and Reduced Lean Body Mass, Nat. Genet., 2000, vol. 26, pp. 97-102.
35. Chen, A.S., Metzger, J.M., Trumbauer, M.E., et al., Role of the Melanocortin-4 Receptor in Metabolic Rate and Food Intake in Mice, Transgenic Res., 2000, vol. 9, pp. 145-154.
36. Abu-Elheiga, L., Matzuk, M.M., Abo-Hasema, K.A.H., and Wakil, S.J., Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2, Science, 2001, vol. 291, pp. 2613-2616.
37. Evans, M.J., Smithies, O., and Capecchi, M.R., Generating Mice with Targeted Mutations, Nat. Med., 2001, vol. 7, pp. 8-12.
38. Beglopoulos, V. and Shen, J., Gene-Targeting Technologies for the Study of Neurological Disorders, NeuroMol. Med., 2004, vol. 6, pp. 13-30.
39. Saura, C.A., Choi, S.-Y., Beglopoulos, V., et al., Loss of Presenilin Function Causes Impairments of Memory and Synaptic Plasticity Followed by Age-Dependent Neurodegeneration, Neuron, 2004, vol. 42, pp. 23-36.
40. Timmons, L. and Fire, A., Specific Interference by Ingested dsRNA, Nature, 1998, vol. 395, p. 854.
41. Fire, A., Xu, S., Montgomery, M.K., et al., Potent and Specific Genetic Interference by Double-Stranded RNA in Caenorhabditis elegans, Nature, 1998, vol. 391, pp. 806-811.
42. Daneholt, B., RNA Interference, http://nobelprize.org/nobel_prizes/medicine/laureates/2006/adv.html.
43. Aza-Blanc, P., Cooper, C.L., Wagner, K., et al., Identification of Modulators of TRAIL Induced Apoptosis via RNAi-Based Phenotypic Screening, Mol. Cell, 2003, vol. 12, pp. 627-637.
44. Sarantseva, S.V., Bol'shakova, O.I., Timoshenko, S.I., et al., Studying the Pathogenesis of Alzheimer's Disease in a Drosophila melanogaster Model: Human APP Overexpression in the Brain of Transgenic Flies Leads to Deficit of the Synaptic Protein Synaptotagmin, Russ. J. Genet., 2009, vol. 45, no. 1, pp. 119-126.
45. Zambrowicz, B.P., Friedrich, G.A., Buxton, E.C., et al., Disruption and Sequence Identification of 2.000 Genes in Mouse Embryonic Stem Cells, Nature, 1998, vol. 392, pp. 608-611.
46. Govorkova, E.A., Webby, R.J., Humberd, J., et al., Immunization with Reverse-Genetics-Produced H5N1 Influenza Vaccine Protects Ferrets against Homologous and Heterologous Challenge, J. Infect. Dis., 2006, vol. 194, pp. 159-167.
47. Hardy, J. and Selkoe, D.J., The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics. An Updated Summary of the Amyloid Hypothesis, Science, 2002, vol. 297, pp. 353-356.
48. Cao, W., Song, H.J., Gangi, T., et al., Identification of Novel Genes That Modify Phenotypes Induced by Alzheimer's {;Beta};-Amyloid Overexpression in Drosophila, Genetics, 2008, vol. 178, pp. 1457-1467.
49. Finelli, A., Kelkar, A., Ho-Juhn Song, et al., A Model for Studying Alzheimer's AB42-Induced Toxicity in Drosophila melanogaster, Mol. Cell. Neurosci., 2004, vol. 26, pp. 365-375.
50. Iwata, N., Tsubuki, S., Takaki, Y., et al., Metabolic Regulation of Brain Ah by Neprilysin, Science, 2001, vol. 292, pp. 1550-1552.
51. Marr, R.A., Rockenstein, E., Mukherjee, A., et al., Neprilysin Gene Transfer Reduces Human Amyloid Pathology in Transgenic Mice, J. Neurosci., 2001, vol. 23, pp. 1992-1996.
52. Iwata, N., Higuchi, M., and Saido, T., Metabolism of Amyloid-β Peptide and Alzheimer's Disease, Pharmacol. Ther., 2005, vol. 108, pp. 129-148.
53. Spillantini, M.G., Bird, T.D., and Ghetti, B., Frontotemporal Dementia Andarkinsonism Linked to Chromosome 17: A New Group of Taupathies, Brain Pathol., 1998, vol. 8, pp. 387-402.
54. Illarioshkin, S.N., Konformatsionnye bolezni mozga (Conformational Brian Diseases), Moscow: Yanus-K, 2003.
55. Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, Z., et al., Mutation-Specific Functional Impairments in Distinct Tau Isoforms of Hereditary FTDP-17, Science, 1998, vol. 282, pp. 1914-1917.
56. Wittmann, C.W., Wszolek, J.M., Shulman, P.M., et al., Tauopathy in Drosophila: Neurodegeneration without Neurofibrillary Tangles, Science, 2001, vol. 293, pp. 711-714.
57. Shulman, J.M. and Feany, M.B., Genetic Modifiers of Tauopathy in Drosophila, Genetics, 2003, vol. 165, pp. 1233-1242.
58. Kraemer, B.C., Burgess, J.K., Chen, J.H., et al., Molecular Pathways that Influence Human Tau-Induced Pathology in Caenorhabditis elegans, Hum. Mol. Genet., 2006, vol. 15, pp. 1483-1496.
59. Kraemer, B.C., Zhang, B., Leverenz, J.B., et al., Neurodegeneration and Defective Neurotransmission in a Caenorhabditis elegans Model of Tauopathy, Proc. Natl. Acad. Sci. USA, 2003, vol. 100, pp. 9980-9985.
60. Karsten, S.L., Sang, T.K., Gehman, L.T., et al., A Genomic Screen for Modifiers of Tauopathy Identifies Puromycin-Sensitive Aminopeptidase as an Inhibitor of Tau-Induced Neurodegeneration, Neuron, 2006, vol. 51, pp. 549-560.
61. -/- Mice: c-Myb Mutation Causes Supraphysiological Production of Platelets in the Absence of Thrombopoietin Signaling, Proc. Natl. Acad. Sci. USA, 2004, vol. 101, pp. 6553-6558.
62. Emambokus, N., Vegiopoulos, A., Harman, B., et al., Progression through Key Stages of Haemopoiesis Is Dependent on Distinct Threshold Levels of c-Myb, EMBO J., 2003, vol. 22, pp. 4478-4488.
63. Haston C. and Hudson, T., Finding Genetic Modifiers of Cystic Fibrosis, N. Engl. J. Med., 2005, vol. 353, pp. 1509-1511.
64. Huntington's Disease Collaborative Research Group: A Novel Gene Containing a Trinucleotide Repeat that Is Expanded and Unstable on Huntington's Disease Chromosomes, Cell, 2003, vol. 72, pp. 971-983.
65. Gusella, J.F. and MacDonald, M.E., Molecular Genetics: Unmasking Polyglutamine Triggers in Neurodegenerative Disease, Nat. Rev. Neurosci., 2000, vol. 1, pp. 109-115.
66. Gusella, J.F. and Macdonald, M.E., Huntington's Disease: Seeing the Pathogenic Process through a Genetic Lens, Trends Biochem. Sci., 2006, vol. 9, pp. 533-540.
67. Zeng, W., Gillis, T., Hakky, M., et al., Genetic Analysis of the GRIK2 Modifier Effect in Huntington's Disease, BMC Neurosci., 2006, vol. 62, pp. 1-9.
68. Rozmahel, R., Wilschanski, M., Matin, A., et al., Modulation of Disease Severity in Cystic Fibrosis Transmembrane Conductance Regulator Deficient Mice by a Secondary Genetic Factor, Nat. Genet., 1996, vol. 12, pp. 280-287.
69. Zielenski, J., Corey, M., Rozmahel, R., et al., Detection of a Cystic Fibrosis Modifier Locus for Meconium Ileus on Human Chromosome 19q13, Nature Gen., 1999, vol. 22, pp. 128-129.
70. Sauer, S., Konthur, Z., and Lehrach, H., Genome Projects and the Functional-Genomic Era, Combinatorial Chem. High Throughput Screening, 2005, vol. 8, pp. 659-667.
71. Sato, M., Taniguchi, T., and Tanaka, N., The Interferon System and Interferon Regulatory Factor Transcription Factors - Studies from Gene Knockout Mice, Cytokine Growth Factor Rev., 2001, vol. 12, pp. 133-142.
72. Venkatachalam, S. and Donehower, L.A., Murine Tumor Suppressor Models, Mutat. Res., 1998, vol. 400, pp. 391-407.
73. Gingrich, N.A. and Hen, R., Dissecting the Role of the Serotonin System in Neuropsychiatric Disorders Using Knockout Mice, Psychopharmacology, 2001, vol. 155, pp. 1-10.
74. Ezzeldin, H.H. and Diasio, R.B., Genetic Testing in Cancer Therapeutics, Clin. Cancer Res., 2006, vol. 12, pp. 4137-4141.